您的位置: 首页 > 农业专利 > 详情页

innovative jak1 selective inhibitors and their uses
专利权人:
TLL PHARMACEUTICAL; LLC
发明人:
CONGXIN LIANG
申请号:
BR112019005969
公开号:
BR112019005969A2
申请日:
2017.09.30
申请国别(地区):
BR
年份:
2019
代理人:
摘要:
1h-furo [3,2-b] imidazo [4,5-d] pyridine derivatives that are selective jak1 kinase inhibitors useful in the treatment of disorders related to jak1 activities, such as autoimmune diseases or disorders, diseases or disorders inflammatory and cancerous or neoplastic diseases or disorders.derivados de 1h-furo[3,2-b]imidazo[4,5-d]piridina que são inibidores seletivos de quinase jak1, úteis no tratamento de distúrbios relacionados às atividades de jak1, tais como doenças ou distúrbios autoimunes, doenças ou distúrbios inflamatórios e doenças ou distúrbios cancerígenos ou neoplásicos.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充